GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Naturland Holding Zrt (BUD:NATURLAND) » Definitions » Net Income From Continuing Operations

Naturland Holding Zrt (BUD:NATURLAND) Net Income From Continuing Operations : Ft1,420 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Naturland Holding Zrt Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Naturland Holding Zrt's net income from continuing operations for the six months ended in Dec. 2024 was Ft754 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was Ft1,420 Mil.

Naturland Holding Zrt Net Income From Continuing Operations Historical Data

The historical data trend for Naturland Holding Zrt's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Naturland Holding Zrt Net Income From Continuing Operations Chart

Naturland Holding Zrt Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
190.13 345.01 1,351.65 1,220.63 1,489.14

Naturland Holding Zrt Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income From Continuing Operations Get a 7-Day Free Trial 692.77 545.06 605.74 665.98 754.48

Naturland Holding Zrt Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was Ft1,420 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturland Holding Zrt Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Naturland Holding Zrt (BUD:NATURLAND) » Definitions » Net Income From Continuing Operations
Comparable Companies
BUD:NUTEX ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM BOM:500124 NBIX BOM:543904
Traded in Other Exchanges
N/A
Address
Csillagvirag utca 8, Budapest, HUN, 1106
Website
https://www.naturlandholding.hu
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.

Naturland Holding Zrt Headlines

No Headlines